Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John W Mellors, MD
University of Pittsburgh Medical Center
Study Chair - Rajesh T Gandhi, MD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Therapeutics Crs
Birmingham, Alabama, United States
- Stanford Crs
Palo Alto, California, United States
- Ucsf Aids Crs
San Francisco, California, United States
- Harbor-Ucla Med. Ctr. Crs
Torrance, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Beth Israel Deaconess Med. Ctr., Actg Crs
Boston, Massachusetts, United States
- Massachusetts General Hospital Actg Crs
Boston, Massachusetts, United States
- Washington U Crs
St Louis, Missouri, United States
- Columbia P&s Crs
New York, New York, United States
- Cornell Crs
New York, New York, United States
- Harlem Actg Crs
New York, New York, United States
- Ny Univ. Hiv/aids Crs
New York, New York, United States
- Univ. of Rochester Actg Crs
Rochester, New York, United States
- Unc Aids Crs
Chapel Hill, North Carolina, United States
- Duke Univ. Med. Ctr. Adult Crs
Durham, North Carolina, United States
- Metrohealth Crs
Cleveland, Ohio, United States
- Hosp. of the Univ. of Pennsylvania Crs
Philadelphia, Pennsylvania, United States
- Pitt Crs
Pittsburgh, Pennsylvania, United States
- University of Washington Aids Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 30 Sept 2008
- Completion
- 30 Nov 2008
- Last update posted
- 4 Nov 2021
- Registered enrollment
- 53
- Registry id
- NCT00515827
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.